Refine Search
(24)
(319)
(846)
(1727)

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

  • $1,995
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – France”. The report is an essential source of information and analysis on the healthcare, regulato...

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan

  • $1,995
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Japan”. The report is an essential source of information and analysis on the healthcare, regulator...

NEW Asthma and Chronic Obstructive Pulmonary Disease: Asthma Ahead of COPD in Terms of Innovation with the Focus on Targeted Biologic Therapies for Severe Disease Phenotypes

  • $6,995
  • April 2019
Add to Basket Quick View Add to Saved List

Asthma and COPD are both highly prevalent, chronic, inflammatory diseases of the airways and lungs. The asthma market is highly saturated with relatively efficacious standard therapies and the COPD market is also highly saturated with therapies...

NEW Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes

  • $6,995
  • April 2019
Add to Basket Quick View Add to Saved List

The pain therapeutics market has been largely characterized by only incremental product innovation over the last decade, as most market segments continue to be dominated by long-established active pharmaceutical ingredients and mechanisms of ac...

NEW Biomarkers in the Central Nervous System

  • $7,995
  • April 2019
Add to Basket Quick View Add to Saved List

Biomarkers in CNS are expected to be an area that will witness strong growth in the future due to factors such as deeper understanding of the underlying disease pathology, advancements in technologies, and potential of these biomarkers that can...

NEW Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2018

  • $1,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2018” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

NEW Partnerships, Licensing, Investments and M&A Deals and Trends for January 2019 in Pharmaceuticals

  • $1,000
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for January 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) an...

NEW Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals

  • $1,000
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) a...

Global Risk Report Quarterly Update: Q4 2018

  • $1,100
  • March 2019
Add to Basket Quick View Add to Saved List

Global Risk Report is based on GlobalData Country Risk Index (GCRI) which is a unique country risk-rating model that determines the existing and future level of country risk by assessing various qualitative and quantitative factors. The index i...

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) is a cancer of abnormal plasma cells, a type of white blood cell that is normally responsible for producing antibodies in the bone marrow. Significant improvements in progression-free survival and overall survival arrived ...

Multiple Myeloma: Epidemiology Forecast to 2027

  • $3,995
  • March 2019
Add to Basket Quick View Add to Saved List

Multiple myeloma (MM) (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C90.0) is a hematologic cancer that forms in a type of white blood cell called a plasma cell.

In 2017, ...

Osteoporosis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • March 2019
Add to Basket Quick View Add to Saved List

Osteoporosis is a disease in which the density and quality of bone are reduced over time. In a natural process known as remodeling, some of the bone cells dissolve (resorption) and new bone cells grow back (formation). For people with osteoporo...

Chronic Kidney Disease–Mineral Bone Disorders (CKD-MBD): Competitive Landscape to 2027

  • $3,495
  • March 2019
Add to Basket Quick View Add to Saved List

Chronic Kidney Disease–Mineral Bone Disorders (CKD-MBD) is one of the many complications associated with overall CKD. The systemic disorder is identified from high parathyroid hormone and disrupted K+/Ca2+ levels caused by a decreasing glomerul...

Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026

  • $3,495
  • March 2019
Add to Basket Quick View Add to Saved List

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that results in the scarring of lung tissue and changes the lung’s ability to function normally. The most common signs and symptoms of idiopathic pulmonary fibrosis are dyspnea and a ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

  • $1,995
  • March 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Germany”. The report is an essential source of information and analysis on the healthcare, regulat...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks